Key Facts
Initial investment: 29/07/2019
Sector: Health & Education
Fund: Impact
Status: Realised
Investment Highlights
- Opened 15 new clinics post our investment with further geographical expansion planned.
- Promoted the finance director to the position of CEO.
- Strengthened the existing management team through the recruitment of a new finance director, marketing director and deputy medical director.
- Successfully exited the business in 2022, with a revenue increase of 180% over the course of the investment.
Partnership Motivation
Veincentre provides safe, affordable and convenient treatment in an area that lacks NHS funding. We are excited by the opportunity to invest in a business with significant growth potential, through organic growth at existing sites and the rollout of new clinics across the UK, supported by the large, growing, but fragmented market. We are also impressed by management’s reputation in the market and Veincentre’s focus on quality of care which is attractive to consultants who work as part of the group.
I am very proud of what the team has achieved over the last four years, helping more people get successful treatment for their varicose veins. Our strategy has been to grow our clinic base to make our services more accessible, whilst maintaining our high levels of clinical excellence and raising our profile through enhanced marketing campaigns. I am very grateful for the support offered by Palatine and the West family and look forward to our new partnership with CBPE and to continued success.
Veincentre
